Myeloid-derived suppressor cells (MDSCs) in brain cancer: challenges and therapeutic strategies
Mohammad Salemizadeh Parizi(Georgia Institute of Technology), Farnoosh Ebrahimzadeh(Mashhad University of Medical Sciences), Ali Manzouri(Sabzevar University of Medical Sciences), Shohreh Vanaei(University of Tehran), Saeed Abdolhosseini(University of Tehran), Fatemeh Salemizadeh Parizi(Binghamton University)
Cited by 26
Related Papers
An Overview on Materials and Techniques in 3D Bioprinting Toward Biomedical Application
|Engineered Regeneration|2020|306
Microneedle‐Based Generation of Microbubbles in Cancer Tumors to Improve Ultrasound‐Assisted Drug Delivery
|Advanced Healthcare Materials|2019|66
Spectroscopic, molecular docking and molecular dynamic simulation studies on the complexes of β-lactoglobulin, safranal and oleuropein
|International Journal of Biological Macromolecules|2020|44
Presentation of Novel Architecture for Diagnosis and Identifying Breast Cancer Location Based on Ultrasound Images Using Machine Learning
|Diagnostics|2021|37
Role of Myeloid-derived suppressor cell (MDSC) in autoimmunity and its potential as a therapeutic target
|Inflammopharmacology|2021|26